FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma
Syndicate content

Cervical Cancer Deaths news from FierceHealthcare

News

Cervical cancer vaccine used by 25 percent of girls 13 to 17

Well, I'd certainly call this a marketing success: It appears that one in four girls ages 13 to 17 have received Merck & Co.'s new vaccine against cervical cancer, Gardasil. This comes after a... Read more...